Skip to content

Evaluation of a Smartphone Based Screening Tool for Neonatal Jaundice in Surabaya, Indonesia

Evaluation of a Smartphone Based Screening Tool for Neonatal Jaundice in Surabaya, Indonesia

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05623566
Enrollment
284
Registered
2022-11-21
Start date
2018-11-29
Completion date
2019-04-29
Last updated
2024-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaundice, Neonatal

Brief summary

A cross-sectional conductive study aiming to evaluate the accuracy of a novel smartphone application that estimates bilirubin levels in newborns in Surabaya.

Detailed description

A cross-sectional conductive study aiming to evaluate the accuracy of a novel smartphone application that estimates bilirubin levels in newborns at Airlangga University hospital and RSIA Kendangsari MERR in Surabaya. This cross-sectional study evaluates the accuracy of a novel smartphone application that estimates bilirubin levels in Indonesian newborns. The Picterus Calibration Card was placed on the chest of the newborn with the hole in the card placed over the infant's sternum. A validated smartphone with Picterus JP was used to collect digital images.

Interventions

In this study we aim to collect data of newborns with wider range of bilirubin levels to adjust the Picterus JP algorithm and optimize the app performance. This will enable a high qualitative estimation of bilirubin levels in the blood of new-borns for all skin colors.

Sponsors

RSIA Kendangsaru Surabaya
CollaboratorUNKNOWN
Universitas Airlangga
CollaboratorOTHER
Picterus AS
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Hours to 14 Days
Healthy volunteers
Yes

Inclusion criteria

* Infants born with gestational age \>31 * Birth weight ≥ 1500g * Age 0 - ≤14 days * Consent obtained from the parents

Exclusion criteria

* Infants born with congenital abnormalities; * Infants respiratory support; * Infants suffering from a condition that may alter the skin tissue circulatory system, such as sepsis and heart failure; * Infants who have received phototherapy in the last 24 hours.

Design outcomes

Primary

MeasureTime frameDescription
Enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.5-10 minutesEvaluate of smartphone-based screening tool (Picterus JP) for neonatal jaundice in Indonesian newborns.

Secondary

MeasureTime frameDescription
Correlation between bilirubin estimates in from a smartphone application and bilirubin measurements in serum in newborn1-2 minutesTo evaluate the correlation between bilirubin estimates in from a smartphone application and bilirubin measurements in serum in newborns with varying degree of jaundice
correlation between bilirubin estimates from a smartphone application and bilirubin estimates from a standard transcutaneous device in newborns5-10 minutesTo evaluate the correlation between bilirubin estimates from a smartphone application and bilirubin estimates from a standard transcutaneous device in newborns with varying degree of jaundice
Correlation between bilirubin estimates from a smartphone application and bilirubin estimates from visual inspection in newborns5-10 minutesTo evaluate the correlation between bilirubin estimates from a smartphone application and bilirubin estimates from visual inspection in newborns with varying degree of jaundice

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026